Comparative Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients With Suspected Sarcoidosis

Recruiting N/A Interventional Study
Sarcoidosis Lung Pulmonary Sarcoidosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
150 (estimated)
Sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Sarcoidosis is a multi-systemic granulomatous disease of unknown cause that is characterized by the formation of non-caseous epithelioid cell granulomas. Sarcoidosis involves the respiratory system in \> 90% of cases, usually the hilar and mediastinal nodes, and, less frequently, the lung tissue. Airway involvement, as judged by clinical features, physiologic testing, imaging techniques, bronchosc…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: All patients of suspected pulmonary sarcoidosis scheduled for routine EBUS-TBNA Exclusion Criteria: 1. Patient age less than 18 years 2. Patients with co-morbid conditions like Diabetes mellitus, renal failure, chronic liver disease or any other chronic disease. 3. Patients al…
Contacts

Ajmal Khan, MBBS, MD, DM

+919878678689

drajmal13@gmail.com

CONTACT